Alopecia Prevention During Chemotherapy: From the Benchmark to Real Clinical Practice. A Prospective Study

    February 2024 in “ Journal of Modern Oncology
    Marina A. Lyadova, Tatiana A. Nersesova, Anastasia A. Zhuravleva, Denis S. Fedorinov, Anna A. Dudnik, E. A. Denisova, M. V. Nosova, O. A. Pardabekova, Kristina N. Lisitsyna, Veronika Tuleiko, Olesya A. Bikmurzina
    Image
    Studysummary In this study, researchers found that using the Orbis II scalp cooling device in a single-center setting effectively prevented severe chemotherapy-induced alopecia in 73% of patients with various cancer types, though the authors recommend further studies to explore broader applicability and influencing factors.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →

    Research cited in this study

    9 / 9 results